Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | |
| Assets | ||
| Current Assets | ||
| TOTAL | $N/A | $N/A |
| Non-Current Assets | ||
| Other Non-Current Assets | 0 | 164 |
| TOTAL | $N/A | $164 |
| Total Assets | $N/A | $164 |
| Liabilities | ||
| Current Liabilities | ||
| Accrued Expenses | N/A | 91 |
| TOTAL | $N/A | $144 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $N/A | $144 |
| Shareholders' Equity | ||
| Shares Outstanding, K | 14,805 | 14,805 |
| Retained earnings | N/A | -5 |
| TOTAL | $N/A | $20 |
| Total Liabilities And Equity | $0 | $164 |